Safety and Effectiveness of Eye90 Microspheres™ in the Treatment of Unresectable Hepatocellular Carcinoma (HCC) and Metastatic Colorectal Cancer (mCRC)

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

November 2, 2021

Primary Completion Date

November 13, 2023

Study Completion Date

November 13, 2023

Conditions
Hepatocellular Carcinoma Non-resectableMetastatic Colorectal CancerLiver Cancer
Interventions
DEVICE

Eye90 Microspheres

Y90 glass microspheres

Trial Locations (1)

Unknown

Auckland District Health Board, Grafton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

ABK Biomedical

INDUSTRY